We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Articles

Article

Three Ways to Turn Life Science Suppliers into Partners

A growing number of life science businesses are turning to greater supply chain collaboration for benefits like accelerated time to market, improved quality, reduced risk and more rapid and widespread innovation. But while 68% of executives in this industry say active and meaningful engagement with suppliers is essential to success, far too many, over a third, struggle to implement it.
Article

Host Cell Protein Analysis in Biopharma

Presence of host cell protein (HCP) contaminants in the final product, even at very low levels, may elicit unpredictable and serious immunogenic response in humans. The accurate detection, identification and quantification of HCPs during biotherapeutic development is thus critical in ensuring patient safety, and is a regulatory requirement.
Article

Antimicrobial Resistance – the Rise of Global Superbugs

Antimicrobials have revolutionized medicine by enabling treatments for diseases that would once have proven fatal, however,they have since proven to be a double-edged sword.
A bacterium surrounded by bacteriophage.
Article

Lytic vs Lysogenic – Understanding Bacteriophage Life Cycles

Bacteriophage (phage) are obligate intracellular viruses that specifically infect bacteria. Here we take an overview of their structure, life-cycle and the role they have played in advancing science and medicine.
Article

The Agricultural Perspective on Water Contamination by Pharmaceuticals

Despite centuries of research into drug development, investigation into the environmental impact of pharmaceuticals is a much younger field. If not treated effectively, there is the potential for pharmaceuticals in wastewater to affect the agricultural industry through the use of this contaminated water supply.
Article

Current Trends in Bispecifics, Dual-action and Combination Therapies

It’s becoming increasingly apparent that treatments for complex diseases such as cancer, neurodegenerative diseases and depression are unlikely to target a single molecule in the pathological pathway. Drug developers are turning to new ways to exploit more than one drug target at a time.
An organization chart showing ANOVA above One-Way ANOVA and Two-Way ANOVA
Article

One-Way vs Two-Way ANOVA: Differences, Assumptions and Hypotheses

A key statistical test in research fields including biology, economics and psychology, Analysis of Variance (ANOVA) is very useful for analyzing datasets. Here, we summarize the key differences between these two tests, including the assumptions and hypotheses that must be made about each type of test.
Article

Biosafety and the Agents of Doom

To combat harmful pathogens it is vitally important that scientists have facilities available that enable them to work on them safely. These facilities should prevent the operator from becoming infected with the agent they are working with and prevent the organism from escaping the laboratory setting and potentially initiating new outbreaks of disease.

Cell Culture Quality Control: Blissful Ignorance? content piece image
Article

Cell Culture Quality Control: Blissful Ignorance?

How can quality control efforts keep up with the rapid advances in cellular model research? Read on for insights into challenges in recognizing and managing issues in cell culture quality control.
Article

Safe Guarding Your Food from Harmful Microorganisms and the Impact of Our Changing Climate

Prevention and detection of harmful microorganisms within the food industry, be it in your own kitchen, during the production chain or right back at the producer is imperative to keeping consumers healthy. Changes occurring in our climate are also causing shifts in the niches inhabited by microbes, and scientists must keep ahead of the game to prevent emerging issues.
Advertisement